BackEntrada Therapeutics Overview

Entrada Therapeutics Net Tangible Assets

Track Entrada Therapeutics's net tangible assets ($270M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$270.85M
35.09% YoYΔ $-146.41M vs prior year quarter

Peer average

Loading

Entrada Therapeutics Net Tangible Assets History

Loading

Entrada Therapeutics vs. peers: Net Tangible Assets Comparison

Loading

Entrada Therapeutics Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Entrada Therapeutics (TRDA) FAQ

As of the most recent data (March 2026), TRDA shows a net tangible assets of $270M. That compares with $420M in the prior-year period — down 35.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, TRDA's net tangible assets is now $270M (was $420M) — a 35.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Entrada Therapeutics is outperforming or lagging.

Tracking TRDA's net tangible assets over time shows whether Entrada Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $270M That compares with $420M in the prior-year period — down 35.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has Entrada Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $270M) with ownership activity and broader fundamentals.